What are the recommended excision margins for basal‑cell carcinoma, cutaneous squamous‑cell carcinoma, and melanoma based on tumor risk factors and anatomic site?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Skin Cancer Resection Margins

Basal Cell Carcinoma (BCC)

For low-risk, well-defined primary BCCs less than 2 cm in diameter, excise with 4-mm clinical margins of normal-appearing skin. 1

Low-Risk BCC Margins

  • 4-mm margins are appropriate for clinically well-defined, low-risk tumors less than 2 cm in diameter and are expected to achieve complete removal in 95% of cases 1
  • Excision should extend to mid-subcutaneous adipose tissue with histologic margin assessment 1
  • Any peripheral rim of erythema around the BCC must be included in the presumed tumor border 1

High-Risk BCC Margins

  • 6-mm or wider margins are necessary for high-risk features including: 1, 2
    • Tumors ≥2 cm in size
    • Poorly defined clinical borders
    • High-risk anatomic locations (ear, lip, scalp, eyelids, nose)
    • Aggressive histologic subtypes (morpheaform, infiltrative, micronodular)
    • Recurrent tumors

Alternative Approaches

  • Mohs micrographic surgery is recommended for high-risk BCCs, recurrent lesions, or when tissue preservation is critical in anatomically constrained sites 3, 4
  • Narrow 2-3 mm margins may be considered for well-defined facial BCCs in cosmetically sensitive areas, but carry a 13-24% risk of positive margins requiring re-excision 5

Critical Pitfall: Facial BCCs excised with 1-3 mm margins have unacceptably high positive margin rates (13-24%), making standard 4-mm margins or Mohs surgery preferable to avoid repeat procedures 5


Cutaneous Squamous Cell Carcinoma (SCC)

For low-risk, well-defined primary SCCs, excise with 4-mm clinical margins; for high-risk SCCs, use 6-mm or wider margins. 1, 2

Low-Risk SCC Margins

  • 4-mm margins are adequate for most primary SCCs with low-risk features 1, 2
  • The NCCN guidelines recommend 4-6 mm clinical margins for standard excision of low-risk SCC 1
  • Excision should extend to mid-subcutaneous adipose tissue 1

High-Risk SCC Margins

  • Minimum 6-mm margins are recommended for tumors with any of these features: 2
    • Size ≥2 cm in diameter
    • Histologic grade 2 or higher (poorly differentiated)
    • Invasion into subcutaneous tissue
    • High-risk anatomic locations (ear, lip, scalp, eyelids, genitalia)
    • Perineural invasion
    • Immunosuppressed patients

Large Tumors

  • For SCCs >20 mm in area without other high-risk factors that can be repaired primarily, 10-mm clinical margins may be used 4

Alternative Approaches

  • Mohs micrographic surgery or resection with complete circumferential peripheral and deep margin assessment is recommended for high-risk SCCs 4

Critical Pitfall: Underestimating clinical tumor borders is common—any erythema surrounding the visible SCC must be considered part of the tumor when planning margins 1


Melanoma

For invasive melanoma ≤2 mm Breslow thickness, excise with 1-cm margins; for melanoma >2 mm thickness, excise with 2-cm margins. 6

Melanoma In Situ (MIS)

  • 0.5-1.0 cm margins are recommended for melanoma in situ 6
  • Lentigo maligna type MIS may require wider margins or Mohs surgery due to extensive subclinical extension, particularly on the head and neck 6, 7
  • Mohs micrographic surgery or staged excision with permanent sections may be utilized for MIS on the face, ears, or scalp for tissue-sparing excision 6

T1 Melanoma (≤1.0 mm Breslow thickness)

  • 1-cm margins are recommended based on Level I/II evidence from randomized controlled trials 6
  • This applies to melanomas on the trunk and extremities 6

T2 Melanoma (>1.0 to 2.0 mm Breslow thickness)

  • 1-2 cm margins are recommended, with the specific margin determined by anatomic location and functional/cosmetic considerations 6
  • The American Academy of Dermatology guidelines support both 1-cm and 2-cm margins for this category based on randomized trials 6
  • A minimum 2-cm margin is preferred when feasible to minimize locoregional recurrence risk 6

T3 Melanoma (>2.0 to 4.0 mm Breslow thickness)

  • 2-cm margins are recommended 6
  • The Intergroup Melanoma Trial showed no difference in local recurrence or survival between 2-cm and 4-cm margins 6

T4 Melanoma (>4.0 mm Breslow thickness)

  • 2-3 cm margins are recommended, with 3-cm margins preferred when anatomically feasible 6
  • One randomized trial comparing 1-cm versus 3-cm margins showed significantly increased locoregional recurrence with 1-cm margins 6

Depth of Excision

  • Excision should extend to (but not including) the fascia 6

Special Anatomic Considerations

Head, Neck, and Acral Sites

  • Narrower margins may be necessary to preserve function and cosmesis at anatomically constrained sites 6, 8
  • However, sub-1 cm margins for invasive melanomas at acral or head/neck sites are generally not recommended until further studies are available 6, 8
  • Most prospective randomized trials excluded head, neck, and acral melanomas, limiting evidence for these sites 6

Acral Melanoma Specific Guidance

  • For acral melanoma in situ: 0.5-1.0 cm margins 8
  • For invasive acral melanoma ≤2 mm: 1 cm margins 8
  • For invasive acral melanoma >2 mm: 2 cm margins 8
  • Functional preservation is critical, but margins should not be compromised below 1 cm for invasive disease 8

Sentinel Lymph Node Biopsy (SLNB)

  • SLNB should be performed before or concomitant with wide excision whenever possible 6
  • SLNB is indicated for: 6
    • T1b melanoma (≤1.0 mm with ulceration or 0.8-1.0 mm with or without ulceration)
    • All melanomas >1 mm thickness (≥T2a)
  • SLNB is not indicated for melanoma in situ or T1a melanoma unless other adverse features are present 6

Critical Pitfalls:

  • Never use sub-1 cm margins for invasive melanoma except in highly selected cases at anatomically constrained sites after multidisciplinary discussion 6, 8
  • Failing to perform SLNB before wide excision complicates lymphatic mapping and may compromise staging 6
  • Inadequate initial biopsy depth (shave biopsies) can underestimate Breslow thickness and lead to inappropriate margin selection 7
  • For lentigo maligna melanoma, permanent section analysis of the central debulking specimen is mandatory to identify occult invasive melanoma that would require wider margins 7

References

Guideline

Recommended Excision Margin for Well-Differentiated SCC on the Forearm

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Surgical margins for excision of primary cutaneous squamous cell carcinoma.

Journal of the American Academy of Dermatology, 1992

Research

The art and science of surgical margins for the dermatopathologist.

The American Journal of dermatopathology, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of In Situ Melanoma Diagnosed with Shallow Biopsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acral Melanoma: Evidence‑Based Diagnosis, Staging, and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.